UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours

British journal of cancer, 2022-04, Vol.126 (7), p.1010-1017

2022

Volltextzugriff (PDF)

Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma

Radiotherapy and oncology, 2005-10, Vol.77 (1), p.88-95

2005

Volltextzugriff (PDF)

Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma

Acta oncologica, 2006, Vol.45 (4), p.493-497

2006

Volltextzugriff (PDF)

A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma

Acta oncologica, 2006, Vol.45 (7), p.870-875

2006

Volltextzugriff (PDF)

Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance

NPJ precision oncology, 2020-06, Vol.4 (1), p.15-15, Article 15

2020

Volltextzugriff (PDF)

West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment

Journal of clinical oncology, 2016-07, Vol.34 (20), p.2341-2349

2016

Volltextzugriff (PDF)

Clinical impact of the rapid genomic screening platform for non-small cell lung cancer in Asia-Pacific (LC-SCRUM-AP)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8637-8637

2024

Volltextzugriff (PDF)

A comparative study on costs of cancer and access to medicines in Europe

JOURNAL OF CLINICAL ONCOLOGY, 2020, Vol.38 (15_suppl), p.e19051-e19051

2020

Volltextzugriff (PDF)

Prostasin, A Potential Tumor Marker in Ovarian Cancer- A Pilot Study

Clinics (São Paulo, Brazil), 2009-01, Vol.64 (7), p.641-644

2009

Volltextzugriff (PDF)

Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib

Clinical cancer research, 2018-09, Vol.24 (18), p.4407-4415

2018

Volltextzugriff (PDF)

Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor–positive, human epidermal growth factor receptor 2–negative early-stage breast cancer

European journal of cancer (1990), 2016-10, Vol.66, p.104-113

2016

Volltextzugriff (PDF)

Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer

JOURNAL OF CLINICAL ONCOLOGY, 2021, Vol.39 (15_suppl), p.e16228-e16228

2021

Volltextzugriff (PDF)

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry

NPJ breast cancer, 2017-09, Vol.3 (1), p.32-7, Article 32

2017

Volltextzugriff (PDF)

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients

Breast cancer research and treatment, 2013-07, Vol.140 (1), p.83-92

2013

Volltextzugriff (PDF)

A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer

Advances in therapy, 2015-12, Vol.32 (12), p.1237-1247

2015

Volltextzugriff (PDF)

Clinical concordance study of a 17-gene liquid biopsy NGS panel for non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21065-e21065

2018

Volltextzugriff (PDF)

Genomic profile of breast cancer

Expert review of pharmacoeconomics & outcomes research, 2015-06, Vol.15 (3), p.393-394

2015

Volltextzugriff (PDF)

In the Era of Genomics, Should Tumor Size Be Reconsidered as a Criterion for Neoadjuvant Chemotherapy?

The oncologist (Dayton, Ohio), 2015-04, Vol.20 (4), p.344-350

2015

Volltextzugriff (PDF)

Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney

Acta oncologica, 2008, Vol.47 (8), p.1578-1583

2008

Volltextzugriff (PDF)

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry

NPJ breast cancer, 2017-09, Vol.3 (1), p.33-8, Article 33

2017

Volltextzugriff (PDF)

A pilot laboratory study comparing the 21-gene assay and PAM50-ROR

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.11003-11003

2014

Volltextzugriff (PDF)

A comparative study on costs of cancer and access to medicines in Europe

ANNALS OF ONCOLOGY, 2020, Vol.31 (15), p.S1197

2020

Volltextzugriff (PDF)

Treatments/clinical outcomes in ER+ HER2-negative breast cancer (BC) where treatment decisions were recurrence score (RS)-guided: Analysis by histologic subtype

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12053-e12053

2017

Volltextzugriff (PDF)

Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma (RCC): Validation of the 16-gene Recurrence Score in stage III patients

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4508-4508

2017

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies

First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours

Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma

Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma

A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma

Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance

West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment

Clinical impact of the rapid genomic screening platform for non-small cell lung cancer in Asia-Pacific (LC-SCRUM-AP)

A comparative study on costs of cancer and access to medicines in Europe

Prostasin, A Potential Tumor Marker in Ovarian Cancer- A Pilot Study

Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib

Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor–positive, human epidermal growth factor receptor 2–negative early-stage breast cancer

Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients

A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer

Clinical concordance study of a 17-gene liquid biopsy NGS panel for non-small cell lung cancer (NSCLC)

Genomic profile of breast cancer

In the Era of Genomics, Should Tumor Size Be Reconsidered as a Criterion for Neoadjuvant Chemotherapy?

Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry

A pilot laboratory study comparing the 21-gene assay and PAM50-ROR

A comparative study on costs of cancer and access to medicines in Europe

Treatments/clinical outcomes in ER+ HER2-negative breast cancer (BC) where treatment decisions were recurrence score (RS)-guided: Analysis by histologic subtype

Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma (RCC): Validation of the 16-gene Recurrence Score in stage III patients

Suchergebnisse filtern